(Q34804039)

4 August 2017

1 reference

title

Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer (English)

1 reference

4 August 2017

main subject

head and neck carcinoma

1 reference

Derrick T Lin

1

1 reference

4 August 2017

Kotha Subbaramaiah

2

1 reference

4 August 2017

Jatin P Shah

3

1 reference

4 August 2017

Andrew J Dannenberg

4

1 reference

4 August 2017

Jay O Boyle

5

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

24

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

792-799

1 reference

4 August 2017

cites work

Cancer statistics, 2001

1 reference

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

21 January 2018

1 reference

Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester

21 January 2018

1 reference

v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor

21 January 2018

1 reference

Inhibition of cyclooxygenase-2 gene expression by p53.

21 January 2018

1 reference

Prostaglandin-like material extracted from squamous carcinomas of the head and neck

21 January 2018

1 reference

Prostaglandins and human lung carcinomas

21 January 2018

1 reference

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

Host cyclooxygenase-2 modulates carcinoma growth.

21 January 2018

1 reference

Regulation of the immune response by prostaglandins

21 January 2018

1 reference

Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell

21 January 2018

1 reference

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

Nonsteroidal antiinflammatory drugs and breast cancer

21 January 2018

1 reference

Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent

21 January 2018

1 reference

Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.

21 January 2018

1 reference

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin

21 January 2018

1 reference

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

21 January 2018

1 reference

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells

21 January 2018

1 reference

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

21 January 2018

1 reference

Prostaglandin synthetase dependent activation of 7,8-dihydro-7,8-dihydroxy-benzo(a)pyrene to mutagenic derivatives

21 January 2018

1 reference

Prostaglandin H synthase and xenobiotic oxidation

21 January 2018

1 reference

Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma.

21 January 2018

1 reference

Carcinogen substrate specificity of human COX-1 and COX-2.

21 January 2018

1 reference

Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.

21 January 2018

1 reference

Subversion of immune system by tumor cells and role of prostaglandins

21 January 2018

1 reference

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

21 January 2018

1 reference

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

Tumor-mediated immunosuppression: Prevention by inhibitors of prostaglandin synthesis

21 January 2018

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44

21 January 2018

1 reference

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

21 January 2018

1 reference

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

13-cis-retinoic acid in the treatment of oral leukoplakia

21 January 2018

1 reference

Aspirin and the Risk of Colorectal Cancer in Women

21 January 2018

1 reference

Second primary tumors in patients with oral cancer

21 January 2018

1 reference

7 January 2021

Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells

1 reference

7 January 2021

Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells

1 reference

7 January 2021

Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study

1 reference

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

7 January 2021

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

7 January 2021

Aspirin and reduced risk of esophageal carcinoma

1 reference

7 January 2021

Oral mucosal tumor inhibition by ibuprofen.

1 reference

7 January 2021

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

7 January 2021

Prostaglandin inhibition of T-cell proliferation is mediated at two levels

1 reference

7 January 2021

Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients

1 reference

7 January 2021

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

7 January 2021

Combinatorial chemoprevention of intestinal neoplasia

1 reference

7 January 2021

Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.10108

1 reference

4 August 2017

1 reference